Although marked progress has been made in treatments for CRC (including surgery, radiotherapy, chemotherapy, and targeted antiangiogenic therapy with VEGF or EGFR inhibitors), the prognosis of patients with CRC remains poor [2, 3]. This evidence concerns the gene EGFR and colorectal carcinoma.